Skip to main content
OpenTrials
Completed

NCT Number: NCT05311241

Teleconsultation in Ambulatory Care in France

Teleconsultation is a telemedicine medical act carried out remotely via information and communication technologies. This medical procedure has been legal in France since 2010 and reimbursed by the National Health Insurance under certain conditions since 2018. In 2020, following the COVID-19 epidemic, the lockdowns and the extension of the scope of financial coverage, 17 million teleconsultations have been reimbursed.

To date, few scientific studies have been published in France to precisely describe the use of the service giving access to outpatient teleconsultation, in particular since the major increase in activity linked to the COVID-19 epidemic.

The objective is to describe the use of the service giving access to outpatient teleconsultation carried out in France by teleconsultation companies and compare the use of the teleconsultation service according to the medical density of the territory.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Telehealth Teleconsultation Telemedicine

Sex eligibility

All sexes

Study type

Observational

Primary location

Les Entreprises de Télémédecine

Paris, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient who used the teleconsultation access service with one of the telemedicine companies member of the LET participating in the study
  • Patient residing in France according to the written information (address and or postal code) given at registration to the telemedicine company
  • Teleconsultation service used between August 1, 2021 and November 30, 2021
  • Teleconsultation service used in the context of outpatient care (hospitals excluded)
  • Teleconsultation service used for a teleconsultation with a doctor registered with the Medical Doctors Council in France

Treatment and study plan

Primary outcomes

  1. Rate of patients without a treating doctor

    Time frame: Through the study completion at the time of the teleconsultation, average 1 day

Sponsors and collaborators

Lead sponsor

Les Entreprises de Télémédecine

Other

Registry information

Official study title

Observational Study of the Use of the Service Giving Access to Teleconsultation in France by Telemedicine Companies

Acronym: TELET

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Apr 5, 2022
Registry last updated
Apr 5, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.